IL168059A0 - Benzopyranone compounds, compositions thereof, and methods for treating orpreventing cancer - Google Patents
Benzopyranone compounds, compositions thereof, and methods for treating orpreventing cancerInfo
- Publication number
- IL168059A0 IL168059A0 IL168059A IL16805905A IL168059A0 IL 168059 A0 IL168059 A0 IL 168059A0 IL 168059 A IL168059 A IL 168059A IL 16805905 A IL16805905 A IL 16805905A IL 168059 A0 IL168059 A0 IL 168059A0
- Authority
- IL
- Israel
- Prior art keywords
- cancer
- compositions
- methods
- benzopyranone compounds
- orpreventing
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical class C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41846902P | 2002-10-15 | 2002-10-15 | |
| US10/685,722 US7091235B2 (en) | 2002-10-15 | 2003-10-14 | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| PCT/US2003/032932 WO2004035002A2 (en) | 2002-10-15 | 2003-10-15 | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL168059A0 true IL168059A0 (en) | 2009-02-11 |
Family
ID=32110155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL168059A IL168059A0 (en) | 2002-10-15 | 2005-04-14 | Benzopyranone compounds, compositions thereof, and methods for treating orpreventing cancer |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US7091235B2 (enExample) |
| EP (1) | EP1556374A4 (enExample) |
| JP (1) | JP2006515275A (enExample) |
| KR (1) | KR20050072764A (enExample) |
| CN (1) | CN100457751C (enExample) |
| AU (1) | AU2003286441A1 (enExample) |
| BR (1) | BR0315400A (enExample) |
| CA (1) | CA2502064A1 (enExample) |
| IL (1) | IL168059A0 (enExample) |
| MX (1) | MXPA05003909A (enExample) |
| NZ (1) | NZ539675A (enExample) |
| WO (1) | WO2004035002A2 (enExample) |
| ZA (1) | ZA200503026B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7091235B2 (en) * | 2002-10-15 | 2006-08-15 | Signal Pharmaceuticals, Llc | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| EP1654225A4 (en) * | 2003-08-13 | 2007-11-28 | Amgen Inc | HORMONE RECEPTOR ANTAGONISTS CONCENTRATING MELANIN |
| WO2005019167A2 (en) * | 2003-08-13 | 2005-03-03 | Amgen, Inc. | Melanin concentrating hormone receptor antagonist |
| WO2005028472A1 (en) * | 2003-09-15 | 2005-03-31 | Signal Pharmaceuticals, Llc | Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| WO2006078833A2 (en) * | 2005-01-21 | 2006-07-27 | Janssen Pharmaceutica N.V. | Novel coumarin derivatives as ion channel openers |
| AU2006262190A1 (en) * | 2005-06-24 | 2007-01-04 | Signal Pharmaceuticals, Llc. | Benzopyranone compounds for treating cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US633155A (en) | 1898-02-23 | 1899-09-19 | William W Ramsay | Fence-repairing tool. |
| US5633155A (en) * | 1992-08-19 | 1997-05-27 | Jinro Limited | Expression vector for phytolacca antiviral protein and process for preparing transgenic plant transformed therewith |
| US6444688B1 (en) * | 1995-06-07 | 2002-09-03 | Eli Lilly And Company | Compounds and compositions with nitrogen-containing non-basic side chains |
| US6331562B1 (en) * | 1998-12-30 | 2001-12-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| US6291456B1 (en) * | 1998-12-30 | 2001-09-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| IL144003A0 (en) * | 1998-12-30 | 2002-04-21 | Signal Pharm Inc | Compounds and methods for modulation of estrogen receptors |
| KR20020075388A (ko) | 1999-12-30 | 2002-10-04 | 시그널 파머슈티컬스 인크 | 에스트로겐 수용체의 조절 화합물 및 조절 방법 |
| US7148252B2 (en) * | 2001-10-03 | 2006-12-12 | Signal Pharmaceuticals, Llc | Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis |
| US6620838B1 (en) * | 2002-04-19 | 2003-09-16 | Signal Pharmaceuticals, Inc. | Benzopyrazone compounds, compositions thereof, and methods of treatment therewith |
| WO2003089422A1 (en) * | 2002-04-19 | 2003-10-30 | Signal Pharmaceuticals, Inc. | Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| US7091235B2 (en) * | 2002-10-15 | 2006-08-15 | Signal Pharmaceuticals, Llc | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
-
2003
- 2003-10-14 US US10/685,722 patent/US7091235B2/en not_active Expired - Fee Related
- 2003-10-15 CN CNB2003801043358A patent/CN100457751C/zh not_active Expired - Fee Related
- 2003-10-15 NZ NZ539675A patent/NZ539675A/en unknown
- 2003-10-15 WO PCT/US2003/032932 patent/WO2004035002A2/en not_active Ceased
- 2003-10-15 ZA ZA200503025A patent/ZA200503026B/xx unknown
- 2003-10-15 MX MXPA05003909A patent/MXPA05003909A/es active IP Right Grant
- 2003-10-15 CA CA002502064A patent/CA2502064A1/en not_active Abandoned
- 2003-10-15 BR BR0315400-9A patent/BR0315400A/pt not_active IP Right Cessation
- 2003-10-15 JP JP2004545432A patent/JP2006515275A/ja active Pending
- 2003-10-15 EP EP03777639A patent/EP1556374A4/en not_active Withdrawn
- 2003-10-15 AU AU2003286441A patent/AU2003286441A1/en not_active Abandoned
- 2003-10-15 KR KR1020057006631A patent/KR20050072764A/ko not_active Ceased
-
2005
- 2005-04-14 IL IL168059A patent/IL168059A0/en unknown
-
2006
- 2006-05-09 US US11/431,056 patent/US7358274B2/en not_active Expired - Fee Related
-
2008
- 2008-02-22 US US12/072,011 patent/US7589119B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7091235B2 (en) | 2006-08-15 |
| WO2004035002A2 (en) | 2004-04-29 |
| US20080146648A1 (en) | 2008-06-19 |
| CN1717405A (zh) | 2006-01-04 |
| CN100457751C (zh) | 2009-02-04 |
| WO2004035002A3 (en) | 2004-08-26 |
| EP1556374A2 (en) | 2005-07-27 |
| EP1556374A4 (en) | 2007-12-19 |
| KR20050072764A (ko) | 2005-07-12 |
| US20060194866A1 (en) | 2006-08-31 |
| NZ539675A (en) | 2006-10-27 |
| ZA200503026B (en) | 2006-11-29 |
| JP2006515275A (ja) | 2006-05-25 |
| BR0315400A (pt) | 2005-08-16 |
| MXPA05003909A (es) | 2005-09-30 |
| US7358274B2 (en) | 2008-04-15 |
| US7589119B2 (en) | 2009-09-15 |
| AU2003286441A1 (en) | 2004-05-04 |
| US20040225005A1 (en) | 2004-11-11 |
| CA2502064A1 (en) | 2004-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2671581B8 (en) | Compositions and methods for treating cancer | |
| AU2003230750A1 (en) | Compositions and methods for treating cancer | |
| EP1468118A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
| ZA200503967B (en) | Agent for preventing or treating neuropathy | |
| AU2003293194A8 (en) | Compositions and methods for treating prostate cancer | |
| AU2003262747A8 (en) | Compounds, compositions, and methods | |
| AU2003236527A8 (en) | Compounds, compositions, and methods | |
| AU2003265242A8 (en) | Compounds, compositions, and methods | |
| IL164352A0 (en) | Methods for treating tweak-related conditions | |
| EP1572118A4 (en) | METHOD AND COMPOSITIONS FOR TREATING CANCER WITH 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216 | |
| EP1476067A4 (en) | COMPOSITIONS AND METHODS FOR CANCER | |
| EP1667999A4 (en) | BENZOPYRANONE COMPOUNDS, COMPOSITIONS THEREOF, AND TREATMENT METHOD USING THE SAME | |
| EP1509539A4 (en) | COMPOSITIONS AND METHODS RELATING TO CANCER | |
| EP1551388A4 (en) | COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS COMPRISING THE SAME | |
| EP1469769A4 (en) | NEW COMPOSITIONS AND METHODS AGAINST CANCER | |
| EP1596806A4 (en) | COMPOSITIONS AND METHODS FOR TREATING CANCER USING IGSF9 AND LIV-1 | |
| AU2002308642A1 (en) | Methods for treating cancer | |
| IL168059A0 (en) | Benzopyranone compounds, compositions thereof, and methods for treating orpreventing cancer | |
| AU2003298708A8 (en) | Gpc99 and gpc99a: methods and compositions for treating cancer | |
| EP1469870A4 (en) | NEW COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | |
| AU2003224486A1 (en) | Composition for treating cancer containing n,n-dimethylphytosphingosine | |
| EP1587405A4 (en) | NEW COMPOSITIONS AND METHODS OF CANCER | |
| EP1599214A4 (en) | METHODS AND COMPOSITIONS FOR TREATING UTERINE COLON CANCER | |
| GB0223325D0 (en) | Treating cancer | |
| AU2003295604A8 (en) | Gpc15: methods and compositions for treating cancer |